Cargando…
New Insights into the Use of Liraglutide—Impact on Cardiovascular Risk and Microvascular Outcomes
Despite the availability of many glucose-lowering drugs, patients with type 2 diabetes mellitus (T2DM) often do not achieve the desired effect, and cardiovascular complications remain the leading cause of death in this group of patients. Recently, more and more attention has been paid to the propert...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10136170/ https://www.ncbi.nlm.nih.gov/pubmed/37189777 http://dx.doi.org/10.3390/biomedicines11041159 |